These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4767005)

  • 1. The different responses of blood amino acids and blood glucose to the administration of insulin to patients with acromegaly.
    Zimmermann-Telschow H; Wiegelmann W; Solbach HG; Zimmermann H
    Horm Metab Res; 1973 Nov; 5(6):474-5. PubMed ID: 4767005
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    Yen SS; Siler TM; DeVane GW
    N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of glucose load in oral glucose tolerance tests. Blood glucose, serum insulin, growth hormone and free fatty acids.
    Christensen NJ; Orskov H; Hansen AP
    Acta Med Scand; 1972 Oct; 192(4):337-42. PubMed ID: 5081072
    [No Abstract]   [Full Text] [Related]  

  • 4. [The content of somatotropic hormone, inorganic phosphorus and nonesterified fatty acids in the blood serum of patients with acromegaly in various therapeutic effects].
    Balabolkin MI
    Probl Endokrinol Gormonoter; 1966; 12(2):40-4. PubMed ID: 6002141
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth hormone-induced enhancement of insulin sensitivity in adipose tissue.
    Batchelor BR; Mahler RJ
    Horm Metab Res; 1972 Mar; 4(2):87-92. PubMed ID: 5028226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Growth hormone, insulin, glucemia and plasmatic free fatty acids after arginine administration (author's transl)].
    Portugal-Alvarez J; Enríquez L; Zamarrón A; Vila T; Catalá E; Velasco-Martín A
    Rev Esp Fisiol; 1973 Dec; 29(4):289-91. PubMed ID: 4791170
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism.
    Sirtori CR; Bolme P; Azarnoff DL
    N Engl J Med; 1972 Oct; 287(15):729-33. PubMed ID: 5056733
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relationship between nitrogen balance and amino acids, free fatty acids, glucose and insulin in human blood under various metabolic conditions (author's transl)].
    Zimmermann-Telschow H; Müller-Wecker H
    Hoppe Seylers Z Physiol Chem; 1976 May; 357(5):695-706. PubMed ID: 823090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal and metabolic studies of the action of fenfluramine in normal man, obesity, acromegaly and diabetes mellitus.
    Sulaiman WR; Johnson RH; Rennie MJ
    Postgrad Med J; 1975; 51 Suppl 1():125-31. PubMed ID: 1219669
    [No Abstract]   [Full Text] [Related]  

  • 10. Growth hormone secretion in primary endogenous hypertriglyceridemia.
    Muggeo M; Fedele D; Tiengo A; Crepaldi G
    Horm Metab Res; 1973 May; 5(3):224-5. PubMed ID: 4714551
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical studies on pituitary growth hormone. II. On the serum level in normal subjects and patients with various disorders].
    Isobe I
    Naika Hokan; 1970 Sep; 17(9):253-69. PubMed ID: 5531456
    [No Abstract]   [Full Text] [Related]  

  • 12. [Free fatty acids, glucose, insulin and growth hormone in the blood of patients with thyroid diseases].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1972 Sep; 111(36):829-32. PubMed ID: 5072749
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth hormone secretion after insulin stimulation in patients with chronic renal failure.
    Kokot F; Kuska J
    Pol Med J; 1972; 11(6):1439-45. PubMed ID: 4659068
    [No Abstract]   [Full Text] [Related]  

  • 14. The somatostatin analogue SMS 201-995 in acromegaly: prolonged, preferential suppression of growth hormone but not pancreatic hormones.
    George SR; Hegele RA; Burrow GN
    Clin Invest Med; 1987 Jul; 10(4):309-15. PubMed ID: 2888554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acromegaly, hypophysectomy and hypothyroidism on plasma glucose, insulin and free fatty acid responses to a glucose load.
    Gutman A; Shafrir E; Reches A; Chowers I
    Isr J Med Sci; 1972 Jun; 8(6):877-80. PubMed ID: 5051829
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperinsulin response to oral leucine in obesity and acromegaly.
    Johnson S; Karam JH; Levin SR; Grodsky GM; Forsham PH
    J Clin Endocrinol Metab; 1973 Sep; 37(3):431-5. PubMed ID: 4785430
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of TRF, propranolol-glucagon, insulin and glucose stimulation tests in acromegaly.
    Coutant G; Vandeweghe M; Vermeulen A
    Horm Metab Res; 1977 Jan; 9(1):17-21. PubMed ID: 403115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Growth hormone releasing factor].
    Shizume K
    Nihon Rinsho; 1984 Jun; 42(6):1483-92. PubMed ID: 6434769
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
    Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
    Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.